VKH
IMGN

Virtu KCG Holdings’s Immunogen Inc IMGN Stock Holding History

Virtu KCG Holdings’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-19,159
Closed -$74K – 3623
2017
Q1 		$74K Sell
19,159
-117,994
-86% -$344K ﹤0.01% 2762
2016
Q4 		$280K Buy
137,153
+108,396
+377% +$218K 0.01% 2186
2016
Q3 		$77K Sell
28,757
-43,048
-60% -$125K ﹤0.01% 2704
2016
Q2 		$221K Buy
+71,805
New +$450K ﹤0.01% 2221
2016
Q1 		– Sell
-14,243
Closed -$193K – 3826
2015
Q4 		$193K Buy
14,243
+595
+4% +$7.32K ﹤0.01% 2740
2015
Q3 		$131K Buy
+13,648
New +$200K ﹤0.01% 2755
2015
Q1 		– Sell
-21,007
Closed -$128K – 4021
2014
Q4 		$128K Sell
21,007
-9,081
-30% -$83K ﹤0.01% 3113
2014
Q3 		$319K Buy
30,088
+5,853
+24% +$66.2K 0.01% 2279
2014
Q2 		$287K Buy
+24,235
New +$304K ﹤0.01% 2625
2014
Q1 		– Sell
-12,711
Closed -$186K – 4201
2013
Q4 		$186K Sell
12,711
-5,560
-30% -$85.4K ﹤0.01% 3165
2013
Q3 		$311K Buy
+18,271
New +$321K ﹤0.01% 2580

Other funds holding IMGN

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Virtu KCG Holdings's IMGN Position: Q2 2017 in Review

Virtu KCG Holdings sold out of Immunogen Inc (IMGN) in Q2 2017, closing a stake of 19,159 shares — an estimated $74K sold.

Virtu KCG Holdings first reported a position in IMGN in Q3 2013 and held it in 11 quarters. The position peaked at $319K in Q3 2014. 157 funds tracked by Wall St. Rank hold IMGN as of Q2 2017.

  • Virtu KCG Holdings reported no remaining Immunogen Inc position as of Q2 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 19,159 Immunogen Inc shares in Q2 2017, an estimated $74K.
  • Virtu KCG Holdings first reported a position in Immunogen Inc in Q3 2013 and held it in 11 quarters.
  • Virtu KCG Holdings's Immunogen Inc position peaked at $319K in Q3 2014.
  • 157 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.